
REJOINDER: Clarification on COA RMLC’s Research and Development Activities Regarding COA-72
We have taken note of a news article published in the Daily Graphic on Wednesday, July 16, 2025, headlined: “COA-72 undergoes clinical trials as anti-HIV drug”. While we commend the media’s interest in Ghanaian-led scientific